Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma.
Arabinda DasFraser HendersonStephen LoweGerald C WallaceWilliam A VandergriftScott M LindhorstAbhay K VarmaLibby K InfingerPierre GiglioNarendra L BanikSunil J PatelDavid CachiaPublished in: Cancer chemotherapy and pharmacology (2018)
DATS may be an effective and well-tolerated therapeutic agent in preventing tumor progression and inducing apoptosis in human GB.